GINER INC — Department of Health and Human Services SBIR Phase I: 86
GINER INC — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $299,949
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- 86
- NAICS
- —
- Place of performance
- MA
- Period
- —
Description
The public health impact of endemic fungal diseases is increasingly becoming more widespread as they have high morbidity and mortality especially in immune-compromised patients. There is an urgent need for early and accurate diagnosis of these diseases. However, current medical diagnostics are insufficient to meet adequate clinical requirements. The overall goal of this project is to develop a low-cost and robust nucleic acid sensor instrument that can rapidly and accurately identify the presence of dimorphic fungal species to yield early and definitive diagnosis of endemic fungal diseases such as Histoplasmosis and Coccidioidomycosis.